January 5, 2022
[UPDATE]: Visit here to view the recording and read a summary.
On January 10th, the COVID Advocates Advisory Board (CAAB), the Coalition to Accelerate and Support Prevention Research (CASPR) and AVAC held a webinar that looked closely at how global health leaders are tackling public resistance to COVID-19 vaccines, and lessons for the HIV field.
View the recording here for Understanding—and Improving—COVID-19 Vaccine Uptake, the first in a series of webinars on vaccine confidence. WACI Health’s Rosemary Mburu will moderate a discussion with:
- John Nkengasong, current director of the Africa Centres for Disease Control and Prevention (and President Biden’s nominee to lead PEPFAR).
- Heidi Larson, founding director of the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine.
- Kate Hopkins, Director of Research, Vaccine Acceptance & Demand at the Sabin Vaccine Institute.
The causes of vaccine hesitancy are complex, but its impact on prolonging pandemics is clear. Low uptake, particularly in countries with widespread access to vaccines, is hobbling the global COVID-19 response. Learning from efforts to build confidence in effective vaccines, and in the health systems that develop, manufacture, approve and distribute them, is essential. These lessons are integral to ending the current pandemic and preparing the field for future vaccines to address HIV, malaria, tuberculosis and whatever pandemic might be next.
This webinar is part of a series hosted by the CAAB and CASPR exploring key topics in pandemic preparedness and response. The series is focused on capturing insights from the response to COVID-19 that will inform public health policy and practice moving forward. For more, visit covidadvocates.org.